secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2026-03-05T23:59:59+00:00
Accession:  0001299130-26-000046
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PacBio appoints Chris Gibson (Recursion co-founder) to board; effective March 3, 2026
--------------------------------------------------------------------------------

- Board expanded to 10; Gibson appointed Class I director with term expiring at 2026 annual meeting.
- Gibson also named to PacBio's Science and Technology Committee.
- He is co-founder and Chairman of Recursion (RXRX), an AI-driven biotech with a drug discovery platform.
- No related party transactions between Gibson and PacBio; standard indemnification agreement to be entered.
- Company cites Gibson's experience in AI, automation, and high-dimensional biology as strategic for HiFi sequencing data tools.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913026000046/0001299130-26-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913026000046/pacb-20260303.htm
  HTML page:      https://secwatch.observer/filing/0001299130-26-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer